Migalastat Hydrochloride
Overview
Migalastat Hydrochloride is an orally administered pharmacological chaperone designed to treat Fabry disease by stabilizing specific mutant forms of the alpha-Galactosidase A enzyme. It aids in trafficking the dysfunctional enzyme to lysosomes, thus potentially restoring its normal function.
API suppliers (6)
Suppliers of Migalastat Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 5 of 6 suppliers.
3 of 6 hold a GMP certificate on record in the EU or UK registers
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- TAPI NL BVNetherlands1 active DMF
- LUPIN MANUFACTURING SOLUTIONS LTD1 active DMF
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
- METROCHEM API PRIVATE LTDIndia1 active DMF
- DIPHARMA SASwitzerland1 active DMF GMP on record
Therapeutic areas
Do you supply Migalastat Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.